This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of Panama
Clinical trial NCT02712359 · COMPLETED
Trial details
- NCT number
- NCT02712359
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-08-22
- Enrollment
- 1201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.